01 · Service
Formulation Development
End-to-end oral dosage form development built around Quality-by-Design principles, ICH guidance, and global regulatory expectations.
Oral solids
- Immediate-release (IR), sustained-release (SR), controlled-release (CR) tablets
- Enteric-coated tablets and capsules
- Multi-unit pellet systems and modified-release matrices
Oral liquids
- Solutions, suspensions, and syrups
- Reconstitutable powders for oral suspension
Development workflow
- Pre-formulation and excipient compatibility studies
- Prototype development and DoE-based optimisation
- Stability programmes aligned to ICH Q1A(R2)
- Scale-up readiness packages for tech transfer
Related services
Explore the rest of the lifecycle.
Injectables
Sterile and non-sterile injectable formulation — solutions, suspensions, lyophilized products, and peptides.
Analytical
Method development, validation, stability, and routine QC analysis to US FDA / EU EMA standards.
Manufacturing
Pilot, BE, pre-clinical, clinical and commercial-scale GMP manufacturing for oral and injectable products.